Literature DB >> 15021892

Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis.

Luca Busino1, Massimo Chiesa, Giulio F Draetta, Maddalena Donzelli.   

Abstract

In eukaryotic cells, control mechanisms of cell-cycle progression have evolved to accurately monitor the integrity of genetic information to be transferred to the progeny. Cdc25A phosphatase is an essential activator of cell-cycle progression and is targeted by checkpoint signals. Ubiquitylation regulates Cdc25A activity through fine tuning of its protein levels. Two different ubiquitin ligases (APC/C and SCF complex) are involved in Cdc25A turnover. While APC/C is involved in regulating Cdc25A at the exit of mitosis, SCF regulates the abundance of Cdc25A in S phase and G2. In response to DNA damage or to stalled replication, the activation of the ATM and ATR protein kinases leads to Chk1 and Chk2 activation and to Cdc25A hyperphosphorylation. These events stimulate SCF-mediated ubiquitylation of Cdc25A and its proteolysis. This contributes to delaying cell-cycle progression, thereby preventing genomic instability. Based on recent findings, we discuss the role of Cdc25A ubiquitylation and degradation in cell-cycle progression and in response to DNA damage. Moreover, we discuss the role of phosphorylation at multiple sites in triggering ubiquitylation signals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021892     DOI: 10.1038/sj.onc.1207394

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

Review 1.  Ubiquitin and SUMO systems in the regulation of mitotic checkpoints.

Authors:  Gustavo J Gutierrez; Ze'ev Ronai
Journal:  Trends Biochem Sci       Date:  2006-05-02       Impact factor: 13.807

2.  p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.

Authors:  H Christian Reinhardt; Aaron S Aslanian; Jacqueline A Lees; Michael B Yaffe
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

3.  Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2.

Authors:  Dipankar Ray; Aarif Ahsan; Abigail Helman; Guoan Chen; Ashok Hegde; Susmita Ramanand Gurjar; Lili Zhao; Hiroaki Kiyokawa; David G Beer; Theodore S Lawrence; Mukesh K Nyati
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

Review 4.  Integrating S-phase checkpoint signaling with trans-lesion synthesis of bulky DNA adducts.

Authors:  Laura R Barkley; Haruo Ohmori; Cyrus Vaziri
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

5.  DNA Damage Response in Xenopus laevis Cell-Free Extracts.

Authors:  Tomas Aparicio Casado; Jean Gautier
Journal:  Methods Mol Biol       Date:  2021

6.  Cdc25A and Dub3 in a high-stakes balancing act.

Authors:  Sebastian D Hayes; J Wade Harper
Journal:  Nat Cell Biol       Date:  2010-04       Impact factor: 28.824

Review 7.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

8.  Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction.

Authors:  Y Honaker; H Piwnica-Worms
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

9.  A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint.

Authors:  Marcel A T M van Vugt; Alexandra K Gardino; Rune Linding; Gerard J Ostheimer; H Christian Reinhardt; Shao-En Ong; Chris S Tan; Hua Miao; Susan M Keezer; Jeijin Li; Tony Pawson; Timothy A Lewis; Steven A Carr; Stephen J Smerdon; Thijn R Brummelkamp; Michael B Yaffe
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

10.  NPM phosphorylation stimulates Cdk1, overrides G2/M checkpoint and increases leukemic blasts in mice.

Authors:  Wei Du; Yun Zhou; Suzette Pike; Qishen Pang
Journal:  Carcinogenesis       Date:  2009-11-23       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.